After paralyzing bike crash, man regains mobility with experimental drug

Pennsylvania biker Larry Williams discusses his experience with the experimental NVG-291 trial, as the injection has helped him move more freely after his accident.

An experimental drug could help to improve movement for patients with spinal cord injuries.

NVG-291, an injectable peptide, has been tested in a phase 2 trial with eligible patients — some of whom noted remarkable outcomes.

Larry Williams, a trial participant based in Philadelphia, Pennsylvania, shared with Fox News Digital that he’s been able to walk again after an accident that caused paralysis.

FOUR FAMILIES ARE DESPERATE TO RAISE FUNDS FOR THEIR CHILDREN’S PARALYZING DISEASE

Williams, 58, was mountain biking on a small trail when he struc

See Full Page